<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>The Doctors Lounge - Endocrinology and Diabetes via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'The Doctors Lounge - Endocrinology and Diabetes' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=The+Doctors+Lounge+-+Endocrinology+and+Diabetes&t=The+Doctors+Lounge+-+Endocrinology+and+Diabetes&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 10 Oct 2009 19:37:54 +0100</lastBuildDate>
        <item>
            <title>BPA (Bisphenol A), used in packaging, is linked to metabolic disorders.</title>
            <link>http://www.medworm.com/index.php?rid=1853149&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Fnews%2Fbisphenol_risk.shtml</link>
            <description>Bisphenol A used in plastic packaging for food and beverages, is associated&amp;nbsp; with risk of metabolic disorders. [JAMA]. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1853149</comments>
            <pubDate>Mon, 06 Oct 2008 07:47:10 +0100</pubDate>
            <guid isPermaLink="false">1853149</guid>        </item>
        <item>
            <title>Byetta (Exenatide) - new once-a-week treatment for type 2 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=1853150&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Fnews%2Fbyetta_diabetes.shtml</link>
            <description>A new once-weekly treatment for type 2 diabetes could replace the more common twice-daily injection. [Lancet]. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1853150</comments>
            <pubDate>Sat, 04 Oct 2008 08:14:42 +0100</pubDate>
            <guid isPermaLink="false">1853150</guid>        </item>
        <item>
            <title>Study to analyze link between PCOS and insulin resistance</title>
            <link>http://www.medworm.com/index.php?rid=1400907&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Fnews%2Fpcos_insulin_resistance.shtml</link>
            <description>New project aims to identify a defective point on the insulin signalling pathway in women with PCOS. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1400907</comments>
            <pubDate>Mon, 18 Jun 2007 08:38:26 +0100</pubDate>
            <guid isPermaLink="false">1400907</guid>        </item>
        <item>
            <title>Actos may reduce cardiovascular risks - study says</title>
            <link>http://www.medworm.com/index.php?rid=1400908&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Fnews%2Fdiabetes_actos_cvs.shtml</link>
            <description>Actos may slow the progression of cardiovascular disease in patients with type 2 diabetes, according to JAMA article. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1400908</comments>
            <pubDate>Tue, 14 Nov 2006 01:56:16 +0100</pubDate>
            <guid isPermaLink="false">1400908</guid>        </item>
        <item>
            <title>Dehydroepiandrosterone (DHEA) found to have no anti-aging effects</title>
            <link>http://www.medworm.com/index.php?rid=1400909&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Fnews%2FDHEA_anti-aging.shtml</link>
            <description>DHEA is found to have no effect on aging markers in a two-year study that appears in New England Journal of Medicine. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1400909</comments>
            <pubDate>Mon, 23 Oct 2006 06:16:38 +0100</pubDate>
            <guid isPermaLink="false">1400909</guid>        </item>
        <item>
            <title>Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics</title>
            <link>http://www.medworm.com/index.php?rid=128241&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Farticles%2Frbx_blindness%2Findex.htm</link>
            <description>Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=128241</comments>
            <pubDate>Mon, 31 Jul 2006 05:20:01 +0100</pubDate>
            <guid isPermaLink="false">128241</guid>        </item>
        <item>
            <title>Canadian study demonstrates new approach to achieving diabetes control</title>
            <link>http://www.medworm.com/index.php?rid=128240&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Farticles%2Fdiabetes_insight%2Findex.htm</link>
            <description>The INSIGHT study demonstrates early addition of insulin glargine therapy safely achieved better glycemic than adding oral agents. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=128240</comments>
            <pubDate>Mon, 31 Jul 2006 05:20:01 +0100</pubDate>
            <guid isPermaLink="false">128240</guid>        </item>
        <item>
            <title>ACTOS shows significant benefits for diabetics</title>
            <link>http://www.medworm.com/index.php?rid=128239&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Farticles%2Fdiabetes%2Factos_cardiovascular%2Findex.htm</link>
            <description>A study shows that ACTOS reduces the risk of cardiovascular events by an extra 16% on top of standard medication. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=128239</comments>
            <pubDate>Mon, 31 Jul 2006 05:20:01 +0100</pubDate>
            <guid isPermaLink="false">128239</guid>        </item>
        <item>
            <title>Heart complications of hyperthyroidism restricted to AF</title>
            <link>http://www.medworm.com/index.php?rid=128238&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Farticles%2Fthyroid%2Fhyperthyroidism_heart%2Findex.htm</link>
            <description>Neither hypo- or hyperthyroidism is associated with a higher risk for other cardiovascular problems. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=128238</comments>
            <pubDate>Mon, 31 Jul 2006 05:20:01 +0100</pubDate>
            <guid isPermaLink="false">128238</guid>        </item>
        <item>
            <title>Five new facts could change our understanding of starvation</title>
            <link>http://www.medworm.com/index.php?rid=128237&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.doctorslounge.com%2Fendocrinology%2Farticles%2Fmetabolism%2Fstarvation_facts%2Findex.htm</link>
            <description>In an article published in The Lancet, Rainer Gross, PhD, UNICEF's chief of nutrition discusses five facts about world hunger. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=128237</comments>
            <pubDate>Mon, 31 Jul 2006 05:20:01 +0100</pubDate>
            <guid isPermaLink="false">128237</guid>        </item>
        <item>
            <title>Thyroglobulin test reveals Thyroid-cancer recurrence early</title>
            <link>http://www.medworm.com/index.php?rid=2913&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fendocrinology%2Farticles%2Fthyroglobulin_cancer%2Findex.htm</link>
            <description>Thyroglobulin level detection, even when there is no sign of a tumor, was correlated with a recurrence of cancer within three to five years in about 80 percent of patients. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2913</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">2913</guid>        </item>
        <item>
            <title>Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics</title>
            <link>http://www.medworm.com/index.php?rid=2912&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fendocrinology%2Farticles%2Frbx_blindness%2Findex.htm</link>
            <description>Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2912</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">2912</guid>        </item>
        <item>
            <title>Canadian study demonstrates new approach to achieving diabetes control</title>
            <link>http://www.medworm.com/index.php?rid=2911&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fendocrinology%2Farticles%2Fdiabetes_insight%2Findex.htm</link>
            <description>The INSIGHT study demonstrates early addition of insulin glargine therapy safely achieved better glycemic than adding oral agents. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2911</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">2911</guid>        </item>
        <item>
            <title>ACTOS shows significant benefits for diabetics</title>
            <link>http://www.medworm.com/index.php?rid=2910&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fendocrinology%2Farticles%2Fdiabetes%2Factos_cardiovascular%2Findex.htm</link>
            <description>A study shows that ACTOS reduces the risk of cardiovascular events by an extra 16% on top of standard medication. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2910</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">2910</guid>        </item>
        <item>
            <title>Heart complications of hyperthyroidism restricted to AF</title>
            <link>http://www.medworm.com/index.php?rid=2909&amp;cid=s_33023_15_f&amp;fid=33023&amp;url=http%3A%2F%2Fwww.thedoctorslounge.net%2Fendocrinology%2Farticles%2Fthyroid%2Fhyperthyroidism_heart%2Findex.htm</link>
            <description>Neither hypo- or hyperthyroidism is associated with a higher risk for other cardiovascular problems. (Source: The Doctors Lounge - Endocrinology and Diabetes)</description>
            <author>The Doctors Lounge - Endocrinology and Diabetes</author>
            <type>info</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2909</comments>
            <pubDate>Fri, 19 May 2006 06:00:00 +0100</pubDate>
            <guid isPermaLink="false">2909</guid>        </item>
    </channel>
</rss>
